Empagliflozin Impurity 150 - Request Quote
Empagliflozin Impurity 150
| SZ CAT No: | SZ-E009215 |
| CAS No | NA |
| Mol.F. | C19H20ClFO5 |
| Mol.Wt. | 382.8 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Empagliflozin Impurity 150 is chemically (2R,3S,4R,5S,6R)-2-(3-chloro-4-(4-fluorobenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol. Empagliflozin Impurity 150 is supplied with detailed characterization data compliant with regulatory guideline. Empagliflozin Impurity 150 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Empagliflozin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Empagliflozin Impurity 150
Purchase Empagliflozin Impurity 150
Empagliflozin Impurity 150 suppliers
Empagliflozin Impurity 150 manufacturers
Empagliflozin Impurity 150 price
Order Empagliflozin Impurity 150
Enquire Empagliflozin Impurity 150
Empagliflozin Impurity 150 cost
Empagliflozin Impurity 150 Supplier
Empagliflozin Impurity 150 Distributor
Empagliflozin Impurity 150 for Method Validation
Empagliflozin Reference Standard
Empagliflozin Impurity 150 for ANDA Filing
Empagliflozin Impurity 150 for Forced Degradation Studies
Empagliflozin Impurity 150 Identification Standards
Empagliflozin Impurity 150 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.